Presentation TCT 2024 CV Event Reduction is the Essential Criterion for Implementing New Device Therapies Presenter: Ori Ben-Yehuda October 30, 2024
Presentation TCT 2024 TCT 870: Prediction Models for the Treatment of Bioprosthetic Aortic Valve Failure in the United States Presenter: Philippe Genereux October 30, 2024
Presentation TCT 2024 TCT 869: Insight From Pre and Post Redo-TAV Computed Tomography Assessment: Implication for Sizing, Positioning and Coronary Risk Presenter: NULL October 30, 2024
Presentation TCT 2024 TCT 868: Potential Pre-TAVR CT Based Computational Modeling Derived Geometric Predictors of Post-TAVR Leaflet Thrombosis in Self-Expandable Valves Presenter: Aniket Venkatesh October 30, 2024
Presentation TCT 2024 TCT 867: Vcal+CT: Detect, evaluate and prevent complications by accurately assessing vascular and valvular calcium Presenter: Victor Alfonso Jimv©nez Dv?az October 30, 2024
Presentation TCT 2024 TCT 866: Regional Left Intraventricular Systolic Pressure Gradients (IVPG) in the Nonobstructive Ventricle and Potential Impact on Invasive and Echo Aortic Valve Gradients Presenter: Safwan Kassas October 30, 2024
Presentation TCT 2024 When Should I Use 2 Stents, Which Technique for Which Anatomy? Presenter: Manish Parikh October 30, 2024
Presentation TCT 2024 When and How Would I Use Septal Ablation to prevent or treat LVOT Obstruction? Presenter: Paul Mahoney October 30, 2024
Presentation TCT 2024 Vulnerable: Beyond the Plaque, Focus on the Patient Presenter: Binita Shah October 30, 2024
Presentation TCT 2024 TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation Presenter: Susheel Kodali October 30, 2024
Presentation TCT 2024 Transcatheter Tricuspid Valve Replacement - Lessons Learned From TRISCEND II Presenter: Charles Davidson October 30, 2024
Presentation TCT 2024 Transcatheter Tricuspid Edge-To-Edge-Repair – Updates from TRILUMINATE and TRI-FR Presenter: Paul Sorajja October 30, 2024
Presentation TCT 2024 Transcatheter Forward-Shifted IVL for Uncrossable Coronary Lesions: First-in-Human Experience Presenter: Julian Strange October 30, 2024
Presentation TCT 2024 TCT 861: CURE-VHD (Comprehensive Unified Regimen for Eliminating Valvular Heart Disease): Using Artificial Intelligence to Identify Patients With Untreated Aortic Stenosis Presenter: Daniel Mitchell October 30, 2024
Presentation TCT 2024 TCT 854: Physiologic Response of Normal Aortic Valves During Dobutamine Stress Presenter: Rob Eerdekens October 30, 2024
Presentation TCT 2024 TCT 710: Long-Term Outcomes of IVUS-Guided Femero-Ilio-Caval Stenting for Iliofemoral Venous Outflow Obstruction: A Retrospective Analysis Presenter: Sanchit Kundal October 30, 2024
Presentation TCT 2024 TCT 709: The Novel Hybrid Nano-coating Ni-Ti stent for below-the-knee atherosclerotic disease: The Newest “Leave the Right Thing Behind”Concept Presenter: Terumitsu Hasebe October 30, 2024
Presentation TCT 2024 TCT 708: Results of a Novel Non-Aspiration-Based Mechanical Thrombectomy for the Treatment of Native Infrainguinal Acute to Chronic Arterial Thrombi and Emboli: The PROWL Registry Presenter: Dean Ferrera October 30, 2024
Presentation TCT 2024 TCT 655: Hemodynamic Effects of Aortic Banding to Simulate Progressive Aortic Stenosis Presenter: Rob Eerdekens October 30, 2024